Technology that helps inform better care and save lives.
Since 1994, BioDot has been the market leader in automated, high-throughput ultra-low volume dispensing systems for the manufacturing of today’s most advanced diagnostics.
BioDot’s proprietary technologies produce more than 3 billion diagnostic tests worldwide each year and are now fundamental in the fight against COVID-19 as well as in various other industrial, life science and medical applications.
Dispensing the smallest, most precise drops at the highest possible speeds.
BioDot enables dispensing of picoliter to nanoliter volumes at the highest possible speeds so companies can do more with less and go to market faster.
BioDot’s installed base is the largest in the world with more than 5,600 platforms in 62 countries, helping produce billions of tests and research outcomes per year.
A trusted partner to more than 2,000 manufacturers and research organizations, BioDot supports customers from R&D to high-volume commercial production.